137 related articles for article (PubMed ID: 38282155)
1. miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway.
Liu S; Wang K; Zhao Z; Pang Y; Liu F; Wang P; Wang Z; Yang X
J Gene Med; 2024 Jan; 26(1):e3649. PubMed ID: 38282155
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer effect of miR-139-3p on laryngeal squamous cell carcinoma by targeting rab5a: In vitro and in vivo studies.
Ma Y; Gong Z; Wang H; Liang Y; Huang X; Yu G
Pathol Res Pract; 2020 Nov; 216(11):153194. PubMed ID: 32916448
[TBL] [Abstract][Full Text] [Related]
3. MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer.
Lu X; Li G; Liu S; Wang H; Chen B
J Ovarian Res; 2021 Jul; 14(1):90. PubMed ID: 34238324
[TBL] [Abstract][Full Text] [Related]
4. miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway.
Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
Biochem Biophys Res Commun; 2022 Sep; 619():76-83. PubMed ID: 35749939
[TBL] [Abstract][Full Text] [Related]
5. Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis.
Lu H; Zheng G; Gao X; Chen C; Zhou M; Zhang L
J Ovarian Res; 2021 Feb; 14(1):30. PubMed ID: 33563314
[TBL] [Abstract][Full Text] [Related]
6. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
Wei GY; Hu M; Zhao L; Guo WS
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.
Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y
J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053
[TBL] [Abstract][Full Text] [Related]
8. Propofol Represses Cell Growth and Metastasis by Modulating the Circular RNA Non-SMC Condensin I Complex Subunit G/MicroRNA-200a-3p/RAB5A Axis in Glioma.
Zhang L; Chen H; Tian C; Zheng D
World Neurosurg; 2021 Sep; 153():e46-e58. PubMed ID: 34129971
[TBL] [Abstract][Full Text] [Related]
9. Rab5a is overexpressed in oral cancer and promotes invasion through ERK/MMP signaling.
Zhang D; Lu C; Ai H
Mol Med Rep; 2017 Oct; 16(4):4569-4576. PubMed ID: 28849149
[TBL] [Abstract][Full Text] [Related]
10. miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1.
Tan J; Li C; Ren L; Zhu X; Hua F; Fu Y
Mol Cell Probes; 2022 Dec; 66():101863. PubMed ID: 36252912
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition.
Zhao Y; Liu XL; Huang JH; Yin AJ; Zhang H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5292-5302. PubMed ID: 32495862
[TBL] [Abstract][Full Text] [Related]
12. Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p.
Li H; Liang J; Wang J; Han J; Li S; Huang K; Liu C
Cancer Commun (Lond); 2021 Jun; 41(6):472-491. PubMed ID: 33638620
[TBL] [Abstract][Full Text] [Related]
13. Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers.
Nguyen NT; Raetz A; Montoya D; Schilling V; Tong C; Brooks RA; Leiserowitz G; Chien J
Gynecol Oncol; 2023 Nov; 178():69-79. PubMed ID: 37806229
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells.
Deng D; Yang S; Wang X
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412051
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways.
Zhang R; Shi H; Ren F; Feng W; Cao Y; Li G; Liu Z; Ji P; Zhang M
J Exp Clin Cancer Res; 2019 Dec; 38(1):494. PubMed ID: 31842953
[TBL] [Abstract][Full Text] [Related]
16. Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis.
Tang Q; Wen H; Hu H; Chen X; Xu S; Fan L; Liu L; Li J
Recent Pat Anticancer Drug Discov; 2024; 19(2):233-246. PubMed ID: 38214360
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.
Pan Y; Wang R; Zhang F; Chen Y; Lv Q; Long G; Yang K
Int J Clin Exp Pathol; 2015; 8(1):384-93. PubMed ID: 25755726
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
Zhou K; Luo X; Wang Y; Cao D; Sun G
Biomed Pharmacother; 2017 Sep; 93():1025-1032. PubMed ID: 28732393
[TBL] [Abstract][Full Text] [Related]
19. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA CASC19 promotes glioma progression by modulating the miR‑454‑3p/RAB5A axis and is associated with unfavorable MRI features.
Wu YJ; Yang QS; Chen H; Wang JT; Wang WB; Zhou L
Oncol Rep; 2021 Feb; 45(2):728-737. PubMed ID: 33416169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
